Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe

被引:9
作者
Debbia, EA [1 ]
Shito, GC [1 ]
Pesce, A [1 ]
Marchese, A [1 ]
机构
[1] Univ Genoa, Sch Med, Inst Microbiol, I-16132 Genoa, Italy
关键词
D O I
10.1007/BF02561662
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
There is an overwhelming consensus on the fact that Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis represent the prevailing bacterial pathogens of community-acquired lower respiratory tract infections, Their specific incidence as causative agents of the more common syndromes is known to vary even profoundly depending on geographic location, and the same holds true for the rates of resistance to antimicrobial drugs. Europe does not escape the threat posed by the present pandemic spread of penicillin resistance in S, pneumoniae although, as expected, countries like Spain and France are greatly affected, while others including Germany, Italy, The Netherlands and the Scandinavian region are comparatively spared,In several sites multiple resistance has been described in S, pneumoniae and the most affected drugs include penicillin, the macrolides, co-trimoxazole and tetracycline, In H, influenzae synthesis of beta-lactamases the main trait of resistance is expressed. Lack of susceptibility to beta-lactams dictated by a different mechanism remains extremely rare. Considerable variations in the incidence of this characteristic are apparent when European countries are considered. France and Spain are again widely affected, while Germany,The Netherlands and Italy display rates of beta-lactamase-positive H, influenzae of about 10%, M, catarrhalis must be considered generally resistant to non-protected aminopenicillins since over 90% of these organisms produce beta-lactamases.
引用
收藏
页码:S9 / S12
页数:4
相关论文
共 21 条
[1]   The enduring pneumococcus: Unfinished business and opportunities for the future [J].
Austrian, R .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1997, 3 (02) :111-115
[2]   Community-acquired pneumonia in adults: Guidelines for management [J].
Bartlett, JG ;
Breiman, RF ;
Mandell, LA ;
File, TM .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) :811-838
[3]   Diagnosis and management of group A streptococcal pharyngitis: A practice guideline [J].
Bisno, AL ;
Gerber, MA ;
Gwaltney, JM ;
Kaplan, EL ;
Schwartz, RH .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) :574-583
[4]  
Craig ADB, 1998, PAIN FORUM, V7, P1
[5]   Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome [J].
Dagan, R ;
Leibovitz, E ;
Greenberg, D ;
Yagupsky, P ;
Fliss, DM ;
Leiberman, A .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (09) :776-782
[6]   Respiratory viruses in acute otitis media [J].
Eskola, J ;
Hovi, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (04) :312-314
[7]  
Felmingham D, 1996, J ANTIMICROB CHEMOTH, V38, P1
[8]  
Gol'dshtein V, 1998, COMBUST THEOR MODEL, V2, P1
[9]   Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae [J].
Johnston, NJ ;
De Azavedo, JC ;
Kellner, JD ;
Low, DE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) :2425-2426
[10]   Management of infections due to antibiotic-resistant Streptococcus pneumoniae [J].
Kaplan, SL ;
Mason, EO .
CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (04) :628-+